article thumbnail

Pharmacy groups call on insurers to preserve vaccine coverage

Beckers Hospital Review

The post Pharmacy groups call on insurers to preserve vaccine coverage appeared first on Becker's Hospital Review | Healthcare News & Analysis. The groups emphasized that the scientific consensus supporting vaccinations as essential tools for disease prevention remains unchanged. .”

article thumbnail

Common drug may limit cancer treatment’s efficacy: Study

Beckers Hospital Review

To evaluate how baseline steroid use can affect immune checkpoint inhibitor therapy, researchers analyzed clinical outcomes of 277 patients with non-small cell lung cancer. and 189 at the University of Southern California in Los Angeles who received immune checkpoint inhibitor therapy, 21 were taking steroids at the start of ICI therapy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Flu Vaccines Are a Go

Pharmacy Times

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

article thumbnail

Surviving a system outage: 4 insights on preparing for a month without technology

Beckers Hospital Review

During a featured session at Becker’s Hospital Review 15th Annual Meeting in April, Eli Tarlow, a healthcare strategist and director with the tech firm CDW, took the stage to confront a sobering reality: health systems must be prepared to deliver care without technology — for as long as a month.

article thumbnail

Efficiency, Education, and Evolution: What’s Next for Pharmacy Practice?

Pharmacy Times

Author(s): Alexandra Gerlach, Associate Editor , Scott A.

article thumbnail

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.

article thumbnail

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

Further, the incidence, severity, and kinetics of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome with CD20 × CD3 TCEs may vary depending on the B-cell lymphoma subtype and the combination partners used, which is a notable consideration for oncology pharmacists when operationalizing these therapies.